Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer

Gastroenterology

Volumn 138, Issue 5, 2010, Pages

  Rahbari, Nuh N ^a   Aigner, Maximilian ^a   Thorlund, Kristian ^b   Mollberg, Nathan ^a   Motschall, Edith ^c   Jensen, Katrin ^a   Diener, Markus K ^a   Büchler, Markus W ^a   Koch, Moritz ^a   Weitz, Jürgen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Circulating Tumor Cells; Colorectal Cancer; Prognosis

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BONE MARROW EXAMINATION; CANCER CELL; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; DISEASE MARKER; HUMAN; META ANALYSIS; OUTCOMES RESEARCH; OVERALL SURVIVAL; PORTAL VEIN BLOOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS;

EID: 77950458280     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.01.008     Document Type: Article

References (69)

1. Ashworth T.R. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aus Med J 14 (1869) 146-149
2. Engell H.C. Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation. Acta Chir Scand Suppl 201 (1955) 1-70
3. Riethdorf S., Wikman H., and Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 123 (2008) 1991-2006
4. Braun S., Vogl F.D., Naume B., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353 (2005) 793-802
5. Parmar M.K., Torri V., and Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17 (1998) 2815-2834
6. Tierney J.F., Stewart L.A., Ghersi D., et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8 (2007) 16
7. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
8. Higgins J.P., and Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] (2009), The Cochrane Collaboration, London, United Kingdom
9. Altman D.G., and Bland J.M. Interaction revisited: the difference between two estimates. BMJ 326 (2003) 219
10. Egger M., Davey S.G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
11. Hardingham J.E., Kotasek D., Sage R.E., et al. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med 1 (1995) 789-794
12. Hardingham J.E., Hewett P.J., Sage R.E., et al. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer 89 (2000) 8-13
13. Bessa X., Elizalde J.I., Boix L., et al. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 120 (2001) 1084-1092
14. Ito S., Nakanishi H., Hirai T., et al. Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett 183 (2002) 195-203
15. Bessa X., Pinol V., Castellvi-Bel S., et al. Prognostic value of postoperative detection of blood circulating tumor cells in patients with colorectal cancer operated on for cure. Ann Surg 237 (2003) 368-375
16. Giacomelli L., Gianni W., Belfiore C., et al. Persistence of epidermal growth factor receptor and interleukin 10 in blood of colorectal cancer patients after surgery identifies patients with high risk to relapse. Clin Cancer Res 9 (2003) 2678-2682
17. Chen W.S., Chung M.Y., Liu J.H., et al. Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery. World J Surg 28 (2004) 552-557
18. Douard R., Wind P., Sales J.P., et al. Long-term prognostic value of detection of circulating colorectal cancer cells using CGM2 reverse transcriptase-polymerase chain reaction assay. Surgery 139 (2006) 556-562
19. Katsumata K., Sumi T., Mori Y., et al. Detection and evaluation of epithelial cells in the blood of colon cancer patients using RT-PCR. Int J Clin Oncol 11 (2006) 385-389
20. Koch M., Kienle P., Kastrati D., et al. Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer. Int J Cancer 118 (2006) 3072-3077
21. Lloyd J.M., McIver C.M., Stephenson S.A., et al. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res 12 (2006) 417-423
22. Allen-Mersh T.G., McCullough T.K., Patel H., et al. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg 94 (2007) 96-105
23. Friederichs J., Gertler R., Rosenberg R., et al. Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma. World J Surg 31 (2007) 2329-2334
24. Koch M., Antolovic D., Kienle P., et al. Increased detection rate and potential prognostic impact of disseminated tumor cells in patients undergoing endorectal ultrasound for rectal cancer. Int J Colorectal Dis 22 (2007) 359-365
25. Sadahiro S., Suzuki T., Maeda Y., et al. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer. Ann Surg Oncol 14 (2007) 1092-1098
26. Koyanagi K., Bilchik A.J., Saha S., et al. Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res 14 (2008) 7391-7396
27. Uen Y.H., Lu C.Y., Tsai H.L., et al. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol 15 (2008) 2120-2128
28. Yie S.M., Lou B., Ye S.R., et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 15 (2008) 3073-3082
29. Wong S.C., Chan C.M., Ma B.B., et al. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Clin Cancer Res 15 (2009) 1005-1012
30. Nakamori S., Kameyama M., Furukawa H., et al. Genetic detection of colorectal cancer cells in circulation and lymph nodes. Dis Colon Rectum 40 suppl (1997) S29-S36
31. Iinuma H., Okinaga K., Adachi M., et al. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer. Int J Cancer 89 (2000) 337-344 20
32. Akashi A., Komuta K., Haraguchi M., et al. Carcinoembryonic antigen mRNA in the mesenteric vein is not a predictor of hepatic metastasis in patients with resectable colorectal cancer: a long-term study. Dis Colon Rectum 46 (2003) 1653-1658
33. Sunouchi K., Machinami R., Mori M., et al. Clinical impact of carcinoembryonic antigen messenger ribonucleic acid expression in tumor-draining vein blood on postoperative liver metastasis in patients with colorectal carcinoma: a prospective, cohort study. Dis Colon Rectum 46 (2003) 467-473
34. Schlimok G., Funke I., Bock B., et al. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8 (1990) 831-837
35. Lindemann F., Schlimok G., Dirschedl P., et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340 (1992) 685-689 19
36. Schott A., Vogel I., Krueger U., et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 227 (1998) 372-379
37. Vogel I., Soeth E., Kalthoff H., et al. Prognostic impact of disseminated tumor cells detected by CK20 RT-PCR in patients with colorectal and gastric carcinoma. Langenbecks Arch Surg (Forumband) 116 (1999) 701-706
38. Leinung S., Wurl P., Schonfelder A., et al. Detection of cytokeratin-positive cells in bone marrow in breast cancer and colorectal carcinoma in comparison with other factors of prognosis. J Hematother Stem Cell Res 9 (2000) 905-911
39. Steinert R., Hantschick M., Vieth M., et al. Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer. Arch Surg 143 (2008) 122-128
40. Taniguchi T., Makino M., Suzuki K., et al. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer 89 (2000) 970-976
41. Yamaguchi K., Takagi Y., Aoki S., et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232 (2000) 58-65
42. Etoh T., Ueo H., Inoue H., et al. Clinical significance of K-Ras mutations in intraoperative tumor drainage blood from patients with colorectal carcinoma. Ann Surg Oncol 8 (2001) 407-412
43. Fujita S., Kudo N., Akasu T., et al. Detection of cytokeratin 19 and 20 mRNA in peripheral and mesenteric blood from colorectal cancer patients and their prognosis. Int J Colorectal Dis 16 (2001) 141-146
44. Guller U., Zajac P., Schnider A., et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 236 (2002) 768-775
45. Sadahiro S., Suzuki T., Ishikawa K., et al. Detection of carcinoembryonic antigen messenger RNA-expressing cells in portal and peripheral blood during surgery does not influence relapse in colorectal cancer. Ann Surg Oncol 12 (2005) 988-994
46. Iinuma H., Okinaga K., Egami H., et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol 28 (2006) 297-306
47. Pantel K., Brakenhoff R.H., and Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8 (2008) 329-340
48. Pierga J.Y., Bonneton C., Vincent-Salomon A., et al. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 10 (2004) 1392-1400
49. Wiedswang G., Borgen E., Schirmer C., et al. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int J Cancer 118 (2006) 2013-2019
50. Soeth E., Vogel I., Roder C., et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 57 (1997) 3106-3110
51. Weitz J., Kienle P., Lacroix J., et al. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res 4 (1998) 343-348
52. Vincent-Salomon A., Bidard F.C., and Pierga J.Y. Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues. J Clin Pathol 61 (2008) 570-576
53. Pantel K., Izbicki J., Passlick B., et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347 (1996) 649-653
54. Wikman H., Vessella R., and Pantel K. Cancer micrometastasis and tumour dormancy. APMIS 116 (2008) 754-770
55. Alix-Panabieres C., Riethdorf S., and Pantel K. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res 14 (2008) 5013-5021
56. Fidler I.J. Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst 45 (1970) 773-782
57. Schlimok G., and Riethmuller G. Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow. Semin Cancer Biol 1 (1990) 207-215
58. Pantel K., and Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev Cancer 4 (2004) 448-456
59. Schmidt-Kittler O., Ragg T., Daskalakis A., et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A 100 (2003) 7737-7742
60. Stoecklein N.H., Hosch S.B., Bezler M., et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 13 (2008) 441-453
61. Lugo T.G., Braun S., Cote R.J., et al. Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol 21 (2003) 2609-2615
62. Higgins J.P., and Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] (2009), The Cochrane Collaboration
63. Deeks J.J., Dinnes J., D'Amico R., et al. Evaluating non-randomised intervention studies. Health Technol Assess 7 (2003) iii-173
64. Atkins D., Best D., Briss P.A., et al. Grading quality of evidence and strength of recommendations. BMJ 19 (2004) 328 1490
65. Guyatt G.H., Oxman A.D., Vist G.E., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008) 924-926
66. Schünemann H., Brozek J., and Oxman A. GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.2 [updated March 2009] (2009), The GRADE Working Group
67. Egger M., Davey S.G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
68. Sterne J.A., Egger M., and Smith G.D. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 323 (2001) 101-105
69. Higgins J.P., and Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] (2009), The Cochrane Collaboration